Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer

Clinical trial NCT02892734 · TERMINATED

Trial details

NCT number: NCT02892734
Sponsor: Northwestern University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2/Neu Negative Recurrent Inflammatory Breast Carcinoma Stage IV Breast Cancer Stage IV Inflammatory Breast Carcinoma

Start date: 2017-09-18
Primary completion: 2019-02-04
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.